Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2022-07-01
2023-02-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Is There a Metabolic Effect of Cinnamon on HbA1c, Blood Pressure and Serum Lipids in Type 2 Diabetes Mellitus?
NCT00846898
The Effects of Crocin Supplementation on Metabolic Parameters, Oxidative Stress, AMP- Activated Protein Kinase and Inflammation-promoting Genes Expression in Peripheral Blood Mononuclear Cells in Patients With Type 2 Diabetes
NCT04163757
Effect of Cinnamon on Glucose and Lipid Levels in Non-Insulin Dependent Type 2 Diabetes Mellitus
NCT00237640
Effects of Cinnamon Supplementation on Glucose Metabolism in Patients With Pre-diabetes
NCT03219411
The Therapeutic Effects of Insulin and Berberine on Stress Hyperglycemia
NCT02806999
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Berberine+Cinnamon (TDS)
The supplements contains 400 mg Berberine, and 200 mg Cinnamon extract
Placebo
Placebo (TDS)
Placebo contains Maltodexterin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Berberine+Cinnamon (TDS)
The supplements contains 400 mg Berberine, and 200 mg Cinnamon extract
Placebo (TDS)
Placebo contains Maltodexterin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed type-2 diabetes mellitus (based on American Diabetes Association criteria)
Exclusion Criteria
* Lactation, pregnancy
* Patients with any malignancy
* Patients with unrelated chronic illness
* Patients with cardiac, liver or respiratory failure
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Nutrition and Food Technology Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Azita Hekmatdoost
Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azita Hekmatdoost
Tehran, Middle East, Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
996401
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.